TheodoreAnthonyBraichMD

PubMed

• A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advan...
  Ramesh K. Ramanathan, Georg A. Bjarnason, Stephen A. Bernard, Philip Desimone, Theodore A. Braich, Joseph P. Evers, William J. M. Hrushesky, Jacques Jolivet> ;Clinical Colorectal Cancer. 2008 Mar 1
• A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors.
  Thierry Delaunoit, Patrick A. Burch, Joel M. Reid, John K. Camoriano, Tomowo Kobayash, Theodore A. Braich, Judith S. Kaur, Joseph Rubin, Charles Erlichman> ;Investigational New Drugs. 2006 Feb 17
• 7 citations
  Phase II trial of KW2189 in patients with advanced malignant melanoma.
  Svetomir N. Markovic, Vera J. Suman, Allen M. Vukov, Tom R. Fitch, David W. Hillman, Alex A. Adjei, Steven R. Alberts, Judith S. Kaur, Theodore A. Braich, John M. Leit...> ;American Journal of Clinical Oncology. 2002 Jun 1
• Phase III Evaluation of Octreotide versus Chemotherapy with 5-Fluorouracil or 5-Fluorouracil Plus Leucovorin in Advanced Exocrine Pancreatic Cancer: A North Central Ca...
  Patrick A. Burch, Margaret Block, Georgene Schroeder, John W. Kugler, Daniel J. Sargent, Theodore A. Braich, James A. Mailliard, John C. Michalak, A. K. Hatfield, Keit...> ;Clinical Cancer Research. 2000 Sep 1
• Long-term results of laparoscopic splenectomy for immune thrombocytopenic purpura.
  Kristi L. Harold, Richard T. Schlinkert, Denise K. Mann, Craig B. Reeder, Pierre Noel, Tom R. Fitch, Theodore A. Braich, John K. Camoriano> ;Mayo Clinic proceedings. 1999 Jan 1
• Laparoscopic Assisted Splenectomy for Treatment of Presumed Immune Thrombocytopenic Purpura: Initial Results
  Richard T. Schlinkert, Theodore A. Braich> ;Mayo Clinic proceedings. 1994 May 1
• Phase II trial of edatrexate in small cell lung cancer
  Martin Wiesenfeld, James R. Jett, John Q. Su, Theodore A. Braich, Carl G. Kardinal, James A. Mailliard, Michael H. Veeder, Roscoe F. Morton, John C. Michalak> ;Cancer. 1994 Feb 15
• Phenotypic and functional analysis of 1,25-dihydroxyvitamin D3 receptor mediated modulation of the human myeloma cell line RPMI 8226.
  Jean Francois Rossi, Brain G.M. Durie, Christophe Duperray, Theodore Braich, Samuel L. Marion, J. Wesley Pike, Mark R. Haussler, Charles Janbon, Régis Bataille> ;Cancer Research. 1988 Mar 1
• Interferon alfa-2b-cyclophosphamide combination studies: in vitro and phase I-II clinical results.
  Brian G.M. Durie, Lawrence H. Clouse, Theodore Braich, Meredith Grimm, Aurelia Robertone> ;Seminars in Oncology. 1986 Sep 1
• Terminal lymphoblastic transformation in polycythemia vera.
  Theodore A. Braich, Thomas M. Grogan, Mary J. Hicks, Bernard R. Greenberg> ;The American Journal of Medicine. 1986 Feb 1
• Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma.
  Theodore Braich, Sydney E. Salmon, Aurelia Robertone, David S. Alberts, Stephen E. Jones, Thomas P. Miller, Harinder S. Garewal> ;Investigational New Drugs. 1986 Jan 1
• Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclo...
  Edmonson, J. H., Hartmann, L. C., Long, H. J., Colon-Otero, G., Fitch, T. R., Jefferies, J. A., Braich, T. A., Maples, W. J.> ;Cancer. 1992 Nov 15
• Lobular carcinoma in situ.
  Braich, T. A.> ;Ariz Med. 1985 Feb 01
• Phase II trial of 4'-deoxydoxorubicin (esorubicin) in hormone resistant prostate cancer.
  Braich, T., Ahmann, F. R., Garewal, H. S., Robertone, A., Salmon, S. E.> ;Invest New Drugs. 1986 Jan 01
• Join now to see all